The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-khatib, K.
Right arrow Articles by Carr, D. J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-khatib, K.
Right arrow Articles by Carr, D. J. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2004, 172: 5638-5647.
Copyright © 2004 by The American Association of Immunologists

Distinctive Roles for 2',5'-Oligoadenylate Synthetases and Double-Stranded RNA-Dependent Protein Kinase R in the In Vivo Antiviral Effect of an Adenoviral Vector Expressing Murine IFN-{beta}1

Khaldun Al-khatib*, Bryan R. G. Williams{dagger}, Robert H. Silverman{dagger}, William Halford{ddagger} and Daniel J. J. Carr2,*

* Departments of Ophthalmology, Microbiology, and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104; {dagger} Department of Cancer Biology/NB40, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195; and {ddagger} Program in Molecular Pathogenesis and Immunity, Tulane University Medical Center, New Orleans, LA 70112

To evaluate the anti-HSV-1 mechanisms of murine IFN-{beta} in ocular infection, mice were transduced with an adenoviral vector expressing murine IFN-{beta} (Ad:IFN-{beta}). Ocular transduction with Ad:IFN-{beta} resulted in enhanced survival following infection with HSV-1. The protective effect was associated with a reduction in 1) viral titer, 2) viral gene expression, 3) IFN-{gamma} levels, and 4) the percentage of CD8+ T lymphocyte and NK cell infiltration in infected tissue. Expression of IFN-{beta} resulted in an elevation of the IFN-induced antiviral gene 2',5'-oligoadenylate synthetase (OAS1a) but not dsRNA-dependent protein kinase R (PKR) in the cornea and trigeminal ganglion (TG). Mice deficient in the downstream effector molecule of the OAS pathway, RNase L, were no more sensitive to ocular HSV-1 compared with wild-type controls in the TG based on measurements of viral titer. However, the efficacy of Ad:IFN-{beta} was transiently lost in the eyes of RNase L mice. By comparison, PKR-deficient mice were more susceptible to ocular HSV-1 infection, and the antiviral efficacy following transduction with Ad:IFN-{beta} was significantly diminished in the eye and TG. These results suggest that PKR is central in controlling ocular HSV-1 infection in the absence of exogenous IFN, whereas the OAS pathway appears to respond to exogenous IFN, contributing to the establishment of an antiviral environment in a tissue-restricted manner.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. A. Austin, W. P. Halford, B. R. G. Williams, and D. J. J. Carr
Oligoadenylate Synthetase/Protein Kinase R Pathways and {alpha}beta TCR+ T Cells Are Required for Adenovirus Vector: IFN-{gamma} Inhibition of Herpes Simplex Virus-1 in Cornea
J. Immunol., April 15, 2007; 178(8): 5166 - 5172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Austin, C. James, R. H. Silverman, and D. J. J. Carr
Critical Role for the Oligoadenylate Synthetase/RNase L Pathway in Response to IFN-{beta} during Acute Ocular Herpes Simplex Virus Type 1 Infection
J. Immunol., July 15, 2005; 175(2): 1100 - 1106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.